Literature DB >> 16458229

Pro: Should aspirin be continued after cardiac surgery in the setting of thrombocytopenia?

Nauder Faraday1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16458229      PMCID： PMC1534120          DOI： 10.1053/j.jvca.2005.10.006

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  11 in total

Review 1.  Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

Authors:  D L Bhatt; E J Topol
Journal:  JAMA       Date:  2000-09-27       Impact factor: 56.272

2.  Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.

Authors:  S Goldman; J Copeland; T Moritz; W Henderson; K Zadina; T Ovitt; J Doherty; R Read; E Chesler; Y Sako
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

3.  Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study.

Authors:  G A Pantely; S H Goodnight; S H Rahimtoola; B J Harlan; H DeMots; L Calvin; J Rösch
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

Review 4.  Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-15

5.  Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.

Authors:  J H Chesebro; V Fuster; L R Elveback; I P Clements; H C Smith; D R Holmes; W T Bardsley; J R Pluth; R B Wallace; F J Puga
Journal:  N Engl J Med       Date:  1984-01-26       Impact factor: 91.245

6.  The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.

Authors:  G V Sharma; S F Khuri; M Josa; E D Folland; A F Parisi
Journal:  Circulation       Date:  1983-09       Impact factor: 29.690

7.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release.

Authors:  L A Harker; T W Malpass; H E Branson; E A Hessel; S J Slichter
Journal:  Blood       Date:  1980-11       Impact factor: 22.113

8.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

9.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

10.  Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.

Authors:  N Zimmermann; A Wenk; U Kim; P Kienzle; A-A Weber; E Gams; K Schrör; T Hohlfeld
Journal:  Circulation       Date:  2003-07-21       Impact factor: 29.690
View more
  4 in total

1.  Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia.

Authors:  Syed Wamique Yusuf; Cezar Iliescu; Jaya D Bathina; Iyad N Daher; Jean-Bernard Durand
Journal:  Tex Heart Inst J       Date:  2010

2.  Risks and benefits of giving early Aspirin within 6 hours of CABG: A retrospective analysis.

Authors:  Muhammad Yasir Khan; Adnan Zafar Khan; Anjum Jalal; Haider Zaman
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

3.  Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease.

Authors:  Hugh Gallagher; Jennifer Dumbleton; Tom Maishman; Amy Whitehead; Michael V Moore; Ahmet Fuat; David Fitzmaurice; Robert A Henderson; Joanne Lord; Kathryn E Griffith; Paul Stevens; Maarten W Taal; Diane Stevenson; Simon D Fraser; Mark Lown; Christopher J Hawkey; Paul J Roderick
Journal:  Trials       Date:  2022-04-21       Impact factor: 2.728

4.  Does Early Post-operative Administration of Aspirin Influence the Risk of Bleeding After Coronary Artery Bypass Graft Surgery? A Prospective Observational Study.

Authors:  Seyed Mahmood Nouraei; Afshin Gholipour Baradari; Amir Emami Zeydi
Journal:  Med Arch       Date:  2015-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.